person · Reporting owner
Molsbergen Tamaro Martina
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BIO-PATH HOLDINGS, INC.BPTH · Entity 9692 | Director | March 31, 2021 | April 01, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BIO-PATH HOLDINGS, INC.
Report date March 31, 2021 · Filed April 01, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.02 · Expires 2031-03-31 | Direct | 10,000 |
Reported balance
After 2021-03-31 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-03-31 · Grant · Acquired 10,000 · Balance 10,000 F1: This option vests over a one-year period, with the shares vesting in equal monthly increments equal to one-twelfth (1/12) of the 10,000 shares, based on continuing service to Bio-Path Holdings, Inc. |
Filing footnotes · ownership attribution and instrument terms
F1: This option vests over a one-year period, with the shares vesting in equal monthly increments equal to one-twelfth (1/12) of the 10,000 shares, based on continuing service to Bio-Path Holdings, Inc.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 31, 2021 Filed Apr 1, 2021 00:20 UTC | BIO-PATH HOLDINGS, INC. BPTH · Entity 9692 | GrantCommon Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $7.02 | $0.00 |
DisclosureSEC source: 0001791926-21-000001 · primary_doc.xml · derivative · entry 1 Molsbergen Tamaro Martina · CIK 0001791926 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2031-03-31 F1 · derivative.exercise_date: This option vests over a one-year period, with the shares vesting in equal monthly increments equal to one-twelfth (1/12) of the 10,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| March 27, 2020 Filed Mar 31, 2020 20:25 UTC | BIO-PATH HOLDINGS, INC. BPTH · Entity 9692 | GrantCommon Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $5.07 | $0.00 |
DisclosureSEC source: 0001791926-20-000001 · primary_doc.xml · derivative · entry 1 Molsbergen Tamaro Martina · CIK 0001791926 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-03-27 F1 · derivative.exercise_date: This option vests over a one-year period, with the shares vesting in equal monthly increments equal to one-twelfth (1/12) of the 10,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.